You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Roche subsidiary Foundation Medicine announced Friday it has acquired precision oncology firm Lexent Bio to help expand its liquid biopsy platforms and advance cancer care.
Financial and other details of the deal were not disclosed.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.